129 related articles for article (PubMed ID: 36326144)
1. Monocyte chemoattractant protein 1 plasma concentration in blood from varicose veins decreases under venoactive drug treatment.
Zolotukhin I; Golovanova O; Efremova O; Golovina V; Seliverstov E
Int Angiol; 2022 Dec; 41(6):457-463. PubMed ID: 36326144
[TBL] [Abstract][Full Text] [Related]
2. Varicose veins show enhanced chemokine expression.
Solá Ldel R; Aceves M; Dueñas AI; González-Fajardo JA; Vaquero C; Crespo MS; García-Rodríguez C
Eur J Vasc Endovasc Surg; 2009 Nov; 38(5):635-41. PubMed ID: 19729323
[TBL] [Abstract][Full Text] [Related]
3. Are Inflammatory Biomarkers Increased in Varicose Vein Blood?
Lattimer CR; Kalodiki E; Geroulakos G; Hoppensteadt D; Fareed J
Clin Appl Thromb Hemost; 2016 Oct; 22(7):656-64. PubMed ID: 27103338
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of transforming growth factor-beta1 correlates with increased synthesis of nitric oxide synthase in varicose veins.
Jacob T; Hingorani A; Ascher E
J Vasc Surg; 2005 Mar; 41(3):523-30. PubMed ID: 15838489
[TBL] [Abstract][Full Text] [Related]
5. Effects of calcium dobesilate and diosmin-hesperidin on apoptosis of venous wall in primary varicose veins.
Iriz E; Vural C; Ereren E; Poyraz A; Erer D; Oktar L; Gokgoz L; Halit V; Soncul H
Vasa; 2008 Aug; 37(3):233-40. PubMed ID: 18690590
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Micronized Purified Flavonoid Fraction-Based Venoactive Therapy After Endovenous Mechanochemical Obliteration: Prospective Comparative Study.
Khryshchanovich VY; Nebylitsin YS; Kosinets VA
Drugs Real World Outcomes; 2021 Sep; 8(3):349-358. PubMed ID: 33913099
[TBL] [Abstract][Full Text] [Related]
7. Appropriate Surgical Treatment of Symptomatic Primary Varicose Veins Decreases Systemic Inflammatory Biomarkers.
Arase H; Sugasawa N; Kawatani Y; Sugano M; Kurobe H; Fujimoto E; Kitaichi T; Kitagawa T
Ann Vasc Dis; 2019 Sep; 12(3):367-371. PubMed ID: 31636748
[No Abstract] [Full Text] [Related]
8. Endovascular laser therapy for varicose veins: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(6):1-92. PubMed ID: 23074409
[TBL] [Abstract][Full Text] [Related]
9. Plasma endothelin-1 release in normal and varicose saphenous veins.
Mangiafico RA; Malatino LS; Santonocito M; Spada RS; Benedetto FA
Angiology; 1997 Sep; 48(9):769-74. PubMed ID: 9313626
[TBL] [Abstract][Full Text] [Related]
10. Effect of Micronized Purified Flavonoid Fraction Therapy on Endothelin-1 and TNF-α Levels in Relation to Antioxidant Enzyme Balance in the Peripheral Blood of Women with Varicose Veins.
Pietrzycka A; Kózka M; Urbanek T; Stpniewski M; Kucharzewski M
Curr Vasc Pharmacol; 2015; 13(6):801-8. PubMed ID: 26311575
[TBL] [Abstract][Full Text] [Related]
11. Ca(2+)-dependent contraction by the saponoside escin in rat vena cava: implications in venotonic treatment of varicose veins.
Raffetto JD; Khalil RA
J Vasc Surg; 2011 Aug; 54(2):489-96. PubMed ID: 21498026
[TBL] [Abstract][Full Text] [Related]
12. Benefits of venoactive drug therapy in surgical or endovenous treatment for varicose veins: a systematic review.
Mansilha A; Sousa J
Int Angiol; 2019 Aug; 38(4):291-298. PubMed ID: 31284708
[TBL] [Abstract][Full Text] [Related]
13. Identification of differentially expressed genes in human varicose veins: involvement of matrix gla protein in extracellular matrix remodeling.
Cario-Toumaniantz C; Boularan C; Schurgers LJ; Heymann MF; Le Cunff M; Léger J; Loirand G; Pacaud P
J Vasc Res; 2007; 44(6):444-59. PubMed ID: 17643059
[TBL] [Abstract][Full Text] [Related]
14. Development of recommendations for the use of venoactive drugs in the treatment of chronic venous disease - where they are effective and where they are not.
Musil D
Vnitr Lek; 2022; 68(4):234-239. PubMed ID: 36220421
[TBL] [Abstract][Full Text] [Related]
15. Study of association of varicose veins and inflammation by inflammatory markers.
Tiwary SK; Kumar A; Mishra SP; Kumar P; Khanna AK
Phlebology; 2020 Oct; 35(9):679-685. PubMed ID: 32529904
[TBL] [Abstract][Full Text] [Related]
16. Dysregulated apoptosis of the venous wall in chronic venous disease and portal hypertension.
Kun L; Ying L; Lei W; Jianhua Z; Yongbo X; Tao W; Jinyuan T; Haibo C
Phlebology; 2016 Dec; 31(10):729-736. PubMed ID: 26447135
[TBL] [Abstract][Full Text] [Related]
17. Surgical correction of varicose vein disease under micronized diosmin protection (results of the Russian multicenter controlled trial DEFANS).
Pokrovsky AV; Saveljev VS; Kirienko AI; Bogachev VY; Zolotukhin IA; Sapelkin SV; Shvalb PG; Zhukov BN; Vozlubleny SI; Sabelnikov VV; Voskanian YE; Katelnitsky II; Burleva EP; Tolstikhin VY
Angiol Sosud Khir; 2007; 13(2):47-55. PubMed ID: 18004259
[TBL] [Abstract][Full Text] [Related]
18. Decreased PGE₂ content reduces MMP-1 activity and consequently increases collagen density in human varicose vein.
Gomez I; Benyahia C; Louedec L; Leséche G; Jacob MP; Longrois D; Norel X
PLoS One; 2014; 9(2):e88021. PubMed ID: 24505358
[TBL] [Abstract][Full Text] [Related]
19. Varicose veins possess greater quantities of MMP-1 than normal veins and demonstrate regional variation in MMP-1 and MMP-13.
Gillespie DL; Patel A; Fileta B; Chang A; Barnes S; Flagg A; Kidwell M; Villavicencio JL; Rich NM
J Surg Res; 2002 Aug; 106(2):233-8. PubMed ID: 12175972
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous calcifications in legs with chronic venous diseases.
Caggiati A; Mosti G
J Vasc Surg Venous Lymphat Disord; 2022 May; 10(3):689-696. PubMed ID: 35217216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
